Elevated levels of Factor XI are associated with cardiovascular disease in women

Jennifer I Berliner1, Anne C Rybicki, Robert C Kaplan

  • 1Division of Hematology, Cardiology, Epidemiology and Endocrinology, Ullman 903, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

Thrombosis Research
|November 5, 2002
PubMed

Insights

Elevated Factor XI levels are linked to severe coronary artery disease (CAD) in women. This finding suggests Factor XI may play a role in arterial thrombosis, a key factor in heart disease.

Area of Science:

  • Cardiology
  • Hematology
  • Women's Health

Background:

  • Coronary artery disease (CAD) is a leading cause of death in US women.
  • Elevated clotting factors are associated with CAD, but studies in women are limited.
  • Factor XI's role in arterial thrombosis is not well understood.

Purpose of the Study:

  • To investigate the association between Factor XI levels and CAD in women.
  • To compare clotting factor levels in women with and without severe CAD.

Main Methods:

  • Compared Factor XI and other clotting factors in women with normal coronaries versus severe CAD.
  • Utilized cardiac catheterization data for patient selection.
  • Performed statistical adjustments for various cardiovascular risk factors.

Main Results:

  • Women with severe CAD had significantly higher Factor XI levels (128% vs. 82%, p<0.04).
  • The association between Factor XI and CAD remained significant after adjusting for age, diabetes, hypertension, cholesterol, smoking, and BMI.
  • Factor XI was also higher in women with elevated total cholesterol and in older age groups.

Conclusions:

  • Factor XI may be an important factor in arterial thrombosis in women.
  • This study suggests Factor XI's potential role in the pathogenesis of CAD.
  • Further research is warranted to explore Factor XI's clinical significance in cardiovascular disease.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...